RobertASweetMD

PubMed

• 2 citations
  Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: A pilot study.
  Shinnyi Chou, Kenneth N Fish, David A Lewis, Robert A Sweet> ;Neurobiology of Disease. 2023 Sep 1
• 6 citations
  Unveiling the Enigma: Exploring Risk Factors and Mechanisms for Psychotic Symptoms in Alzheimer's Disease through Electronic Medical Records with Deep Learning Models.
  Peihao Fan, Oshin Miranda, Xiguang Qi, Julia Kofler, Robert A Sweet, Lirong Wang> ;Pharmaceuticals. 2023 Jun 21
• 3 citations
  Distorted neurocomputation by a small number of extra-large spines in psychiatric disorders.
  Kisho Obi-Nagata, Norimitsu Suzuki, Ryuhei Miyake, Matthew L MacDonald, Kenneth N Fish, Katsuya Ozawa, Kenichiro Nagahama, Tsukasa Okimura, Shoji Tanaka, Masanobu Kano...> ;Science Advances. 2023 Jun 9
• 3 citations
  Vesicular Glutamate Transporter Changes in the Cortical Default Mode Network During the Clinical and Pathological Progression of Alzheimer's Disease.
  Zhiping Mi, Eric E Abrahamson, Angela Y Ryu, Michael Malek-Ahmadi, Julia K Kofler, Kenneth N Fish, Robert A Sweet, Victor L Villemagne, Julie A Schneider, Elliott J Mu...> ;Journal of Alzheimer's Disease. 2023 Jan 1
• 1 citations
  Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease.
  Peihao Fan, Lang Zeng, Ying Ding, Julia Kofler, Jonathan Silverstein, Joshua Krivinko, Robert A Sweet, Lirong Wang> ;CPT. 2023 Aug 1
• Terminal type-specific cannabinoid CB1 receptor alterations in patients with schizophrenia: a pilot study.
  Shinnyi Chou, Kenneth N Fish, David A Lewis, Robert A Sweet> ;Biorxiv. 2023 Apr 11
• Polygenic risk score penetrance & recurrence risk in familial Alzheimer disease.
  Min Qiao, Annie J Lee, Dolly Reyes-Dumeyer, Giuseppe Tosto, Kelley Faber, Alison Goate, Alan Renton, Michael Chao, Brad Boeve, Carlos Cruchaga, Margaret Pericak-Vance,...> ;Annals of Clinical and Translational Neurology. 2023 May 1
• 3 citations
  Efficacy difference of antipsychotics in Alzheimer's disease and schizophrenia: explained with network efficiency and pathway analysis methods.
  Peihao Fan, Julia Kofler, Ying Ding, Michael Marks, Robert A Sweet, Lirong Wang> ;Briefings in Bioinformatics. 2022 Nov 19
• 8 citations
  Schizophrenia-associated differential DNA methylation in brain is distributed across the genome and annotated to MAD1L1, a locus at which DNA methylation and transcrip...
  Brandon C McKinney, Lora L McClain, Christopher M Hensler, Yue Wei, Lambertus Klei, David A Lewis, Bernie Devlin, Jiebiao Wang, Ying Ding, Robert A Sweet> ;Translational Psychiatry. 2022 Aug 20
• 4 citations
  Trio and Kalirin as unique enactors of Rho/Rac spatiotemporal precision.
  M J Grubisha, R A DeGiosio, Z P Wills, R A Sweet> ;Cellular Signalling. 2022 Oct 1
• 5 citations
  Cell type specific cannabinoid CB1 receptor distribution across the human and non-human primate cortex.
  Shinnyi Chou, Tejis Ranganath, Kenneth N Fish, David A Lewis, Robert A Sweet> ;Scientific Reports. 2022 Jun 10
• 49 citations
  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.
  Zahinoor Ismail, Byron Creese, Dag Aarsland, Helen C Kales, Constantine G Lyketsos, Robert A Sweet, Clive Ballard> ;Nature Reviews. Neurology. 2022 Mar 1
• 4 citations
  The National Institute on Aging Late-Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery.
  Dolly Reyes-Dumeyer, Kelley Faber, Badri Vardarajan, Alison Goate, Alan Renton, Michael Chao, Brad Boeve, Carlos Cruchaga, Margaret Pericak-Vance, Jonathan L Haines, R...> ;Alzheimer's & Dementia. 2022 Oct 1
• Clinical Progression of Baseline Risk States for Mild Cognitive Impairment.
  Sarah M Goldberg, Yanji Zhao, Yu Cheng, Andrea M Weinstein, Swathi Gujral, Sarah B Berman, Robert A Sweet, Meryl A Butters, Oscar L Lopez, Beth E Snitz> ;Journal of Alzheimer's Disease. 2022 Jan 1
• 6 citations
  Fingolimod mitigates synaptic deficits and psychosis-like behavior in APP/PSEN1 mice.
  Josh M Krivinko, Susan L Erickson, Matthew L MacDonald, Megan E Garver, Robert A Sweet> ;Alzheimer's & Dementia. 2022 Jan 1
• 4 citations
  Psychosis in Alzheimer's Disease Is Associated With Increased Excitatory Neuron Vulnerability and Post-transcriptional Mechanisms Altering Synaptic Protein Levels.
  Michael R DeChellis-Marks, Yue Wei, Ying Ding, Cody M Wolfe, Joshua M Krivinko, Matthew L MacDonald, Oscar L Lopez, Robert A Sweet, Julia Kofler> ;Frontiers in Neurology. 2022 Jan 1
• 23 citations
  More than a marker: potential pathogenic functions of MAP2.
  Rebecca A DeGiosio, Melanie J Grubisha, Matthew L MacDonald, Brandon C McKinney, Carlos J Camacho, Robert A Sweet> ;Frontiers in Molecular Neuroscience. 2022 Jan 1
• 9 citations
  A Kalirin missense mutation enhances dendritic RhoA signaling and leads to regression of cortical dendritic arbors across development.
  Melanie J. Grubisha, Tao Sun, Leanna Eisenman, Susan L. Erickson, Shinny-Yi Chou, Cassandra D Helmer, Melody T Trudgen, Ying Ding, Gregg E. Homanics, Peter Penzes, Zac...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Dec 7
• 14 citations
  Altered Parvalbumin Basket Cell Terminals in the Cortical Visuospatial Working Memory Network in Schizophrenia.
  Kenneth N. Fish, Brad R. Rocco, Adam M. DeDionisio, Robert A. Sweet, David A. Lewis, Samuel J. Dienel> ;Biological Psychiatry. 2021 Jul 1
• 24 citations
  Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease
  Mary Ann A. DeMichele-Sweet, Lambertus Klei, Byron Creese, Janet C Harwood, Elise A. Weamer, Lora McClain, Rebecca Sims, Isabel Hernández, Sonia Moreno-Grau, Lluís Tár...> ;Molecular Psychiatry. 2021 Jun 10
• 11 citations
  MAP2 is Differentially Phosphorylated in Schizophrenia, Altering its Function
  Melanie J. Grubisha, X Sun, Matthew L. MacDonald, M Garver, Zhe Sun, Kristina A. Paris, Dhilon S. Patel, RA DeGiosio, David A. Lewis, Nathan A. Yates, Carlos J. Camach...> ;Molecular Psychiatry. 2021 Feb 1
• 2 citations
  Investigating Post-translational Modifications in Neuropsychiatric Disease: The Next Frontier in Human Post-mortem Brain Research
  Melanie J. Grubisha, Robert A. Sweet, Matthew L. MacDonald> ;Frontiers in Molecular Neuroscience. 2021 Jan 1
• Author Correction: Sex differences in dendritic spine density and morphology in auditory and visual cortices in adolescence and adulthood.
  Emily J. Parker, Nathan L. Kindja, Claire E. J. Cheetham, Robert A. Sweet> ;Scientific Reports. 2020 Nov 12
• 3 citations
  Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease.
  Mary Ann A. DeMichele-Sweet, Elise A. Weamer, Lambertus Klei, Dylan T. Vrana, Deborah J. Hollingshead, Howard Seltman, Rebecca Sims, Tatiana Foroud, Isabel Hernández, ...> ;Molecular Psychiatry. 2020 Nov 1
• 20 citations
  Psychosis in Alzheimer’s Disease
  Clive Ballard, Helen C. Kales, Constantine G. Lyketsos, Dag Aarsland, Byron Creese, Roger Mills, Hilde Williams, Robert A. Sweet> ;Current Neurology and Neuroscience Reports. 2020 Oct 13
• Join now to see all

Journal Articles

• Density of Small Dendritic Spines and Microtubule-Associated-Protein-2 Immunoreactivity in the Primary Auditory Cortex of Subjects with Schizophrenia  
  Robert Sweet, MD, Nature
• Laser Capture Microdissection–Targeted Mass Spectrometry: A Method for Multiplexed Protein Quantification Within Individual Layers of the Cerebral Cortex  
  Robert Sweet, MD, Nature